Genomind®, an award-winning company advancing a unique personalized medicine platform, has strengthened its leadership with the appointment of two experienced global leaders, Shawn Patrick O’Brien as CEO, and Kip Olmstead as President, as well as the promotion of David Robbins to Chief Scientific Officer.
October 15, 2018
· 6 min read